Top Markets
#1 CoW Protocol CoW Protocol +84.93%
#2 EXOD EXOD +56.80%
#3 Glidr Glidr +38.25%
#4 Walrus Walrus +36.32%
#5 Humanity Humanity +16.84%
#6 Velvet Velvet +16.00%
#7 Cysic Cysic +15.83%
#8 The Black Bull The Black Bull +14.62%
#9 Tutorial Tutorial +14.59%
#10 Plume Plume +14.14%
Coin of the day
CoW Protocol CoW Protocol
設定
言語
日本
通貨
USD
テーマ
Relevium Technologies Inc. Relevium Technologies Inc.

Relevium Technologies Inc.

RLLVF
株式のランク #37146
Relevium Technologies Inc. operates within the health and wellness sector,... Relevium Technologies Inc. operates within the health and wellness sector, focusing on identifying, assessing, acquiring, and managing various brands and businesses, primarily through e-commerce channels. The company distributes a range of products, including dietary supplements, nutraceuticals, sports nutrition items, and cosmeceuticals, mainly through its Bioganix online brand. It also offers dietary supplements under the LeefyLyfe label and skincare solutions marketed as the Push & Pull System. Additionally, Relevium has developed specialized lines such as Relevium Senior, aimed at older adults for inflammatory conditions affecting joints, heart, and brain, and Relevium Kids, providing nutraceuticals and oral nutritional supplements for children. Headquartered in Montreal, Canada, the company was formerly known as BIOflex Technologies Inc. until it rebranded to Relevium Technologies Inc. in December 2015.
株価
$0.006
最終同期: 2026-08-13
時価総額
$1.98M
変化（1日）
0.00%
変化（1年）
0.00%
国
CA
取引 Relevium Technologies Inc. (RLLVF)

カテゴリー

Healthcare
Relevium Technologies Inc.（RLLVF）の収益
Aug 2026 時点の収益 TTM: 0
Relevium Technologies Inc. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Relevium Technologies Inc. の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US